Changeflow GovPing Pharma & Drug Safety Modified Protein Scaffold Patent by Evolveritas
Routine Notice Added Final

Modified Protein Scaffold Patent by Evolveritas

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

The USPTO published patent application US20260098080A1 for a modified protein scaffold comprising amino acid sequence SEQ ID NO: 115 with specific amino acid modifications in defined positions. The application was filed by Evolveritas Biotechnológiai Korlátolt Felelősségű Társaság, a Hungarian biotechnology company, with eight named inventors. The claimed protein scaffold includes segment formula Ih-mod GX1CX1VX2X3X4X5 and is intended for pharmaceutical preparations, kits, and screening procedures.

What changed

The USPTO published a patent application for a modified protein scaffold invented by Evolveritas Biotechnológiai Korlátolt Felelősségű Társaság. The invention comprises a protein with amino acid sequence SEQ ID NO: 115 containing specific modifications at defined positions, including a segment of general formula Ih-mod GX1CX1VX2X3X4X5 with variable amino acid positions and a required amino acid from the 34-set (Y, I, F, G, V, S) at position 34. The application covers pharmaceutical preparations, kits, and screening procedures using the modified scaffold.

Affected parties including pharmaceutical companies, biotech firms, and researchers working with protein scaffolds should monitor this application for potential freedom-to-operate concerns. The published claims define specific amino acid modifications and position requirements that may overlap with existing scaffold technologies. Inventors and assignees in related fields should review the claim scope to assess any competitive implications.

What to do next

  1. Monitor patent prosecution status
  2. Review claims for freedom-to-operate analysis
  3. Contact patent counsel for licensing inquiries

Archived snapshot

Apr 12, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

A MODIFIED PROTEIN SCAFFOLD AND USE THEREOF

Application US20260098080A1 Kind: A1 Apr 09, 2026

Assignee

EVOLVERITAS BIOTECHNOLÓGIAI KORLÁTOLT FELELOSSÉGU TÁRSASÁG

Inventors

Péter GÁL, Gergo Zsolt GÓGL, Bence KISS, Zsombor KÖLLER, Zoltán Attila NAGY, Zoltán Bálint NÉMETH, Gábor PÁL, Andrea PÁRISNÉ DR KOCSIS

Abstract

A protein comprising amino acid sequence of SEQ ID NO: 115, within which a segment of general formula Ih-mod GX1CX1VX2X3X4X5 is present
whereX1 is any of F, Y, L, P, Q, M, V, W, A, or T,X1V is R, or K,X2 is any of A, G, S, or T,X3 is any amino acid of the 17-set, where the 17-set comprises A, I, L, F, or Y,X4 is any of K, I, Q, R, H, S, F, M, N, L, or V, andX5 is any of R, V, I, K, M, Q, E, F, L, N, Y, D, S, H;andb) in position 34 of SEQ ID NO: 115 it contains an amino acid selected from the 34-set contains any amino acid of the 34-set, where the 34-set comprises Y, I, F, G, V and S, and use in pharmaceutical preparations, kits, screening procedures.

CPC Classifications

C07K 14/8114 C12Y 304/21104 G01N 33/573 A61K 38/00 G01N 2333/96433 G01N 2500/04

Filing Date

2023-09-29

Application No.

19114995

View original document →

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260098080A1
Docket
19114995

Who this affects

Applies to
Pharmaceutical companies Manufacturers Investors
Industry sector
3254.1 Biotechnology
Activity scope
Patent filing Biotechnology research Pharmaceutical development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare Biotechnology

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!